Amarin Corp Plc (AMRN)

[bfost]

sts - About 50% of patients on statins stop taking them within a year of getting a prescription

Approximately 15-20% don't take statins due to intolerance

So we are still talking millions of high risk patients who could potentially benefit from V alone. Although nothing will happen soon I could see a study using V alone in the future (especially if BP owns V). That is still a big market.
As you suggest RWE data may help in this as well.